
TSHA
Taysha Gene Therapies Inc.
$5.10
+$0.22(+4.51%)
58
Overall
60
Value
72
Tech
42
Quality
Market Cap
$1.29B
Volume
3.24M
52W Range
$1.05 - $5.40
Target Price
$9.50
EPS Estimates Overview
Current Quarter | $-0.09 | Next Quarter | $-0.09 |
Current Year | $-0.35 | Next Year | $-0.39 |
QoQ Growth | +0.0% | YoY Growth | -11.4% |
3Y EPS CAGR | +57.4% | Target Price | $9.50 |
Consensus | Buy | Upside | +86.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
Current Quarter Rev | N/A | Next Quarter Rev | N/A |
Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
A | B | C | D | |
---|---|---|---|---|
1 | Symbol | Price | Change | Vol |
2 | TSHA | $5.10 | +4.5% | 3.24M |
3 | ||||
4 | ||||
5 | ||||
6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW